Yet, as time ticks on, our NAD+ production gradually wanes, plummeting by a staggering 40% by the age of 40
As the benefits of the GLP-1 receptor agonists with type 2 diabetes, obesity, and cardiovascular health have become widely known, research has accelerated, and potential new opportunities have risen to utilize GLP-1s to treat other conditions: 1
That distinction matters because skin quality, recovery, and aging-related changes rarely depend on one factor alone
The peptide also interacts with GABAergic and NO systems (PubMed)
Tesamorelin and Ipamorelin are often discussed for their potential role in metabolism, body composition, recovery, and sleep quality without being the same thing as taking growth hormone directly